<DOC>
	<DOCNO>NCT01201902</DOCNO>
	<brief_summary>The purpose study assess safety body 's immune response experimental H1N1 influenza vaccine healthy adult elderly population . The study enroll 590 healthy adult age 18 old history H1N1 infection vaccination . 354 individual 18-64 year old , 236 great equal 65 year age .</brief_summary>
	<brief_title>A Study Evaluate Safety Immunogenicity Inactivated Split-virion Influenza A ( H1N1 ) Vaccine</brief_title>
	<detailed_description>▶ Immunogenicity ( Efficacy ) Outcome Measures : Hemagglutination inhibition assay 1 . Proportion subject , stratify group , seroconversion HI antibody 2 . Proportion subject , stratify group , achieve serum hemagglutination inhibition assay ( HIA ) antibody titer 1:40 great influenza H1N1 2009 virus 3 . GMT ( Geometric Mean Titer ) GMR ( Geometric Mean Ratio ) measure HIA antibody titer - Safety Outcome Measures : 1 . Solicited adverse event ( Day 0 ~ 6 , Day 21 ~ 27 ) 2 . Unsolicited adverse event ( Day 0 ~ 42 ) 3 . Adverse event ( Day 21 ~ 6 month )</detailed_description>
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Healthy adult age 18 older . Are able understand comply plan study procedure . Provide write informed consent prior initiation study procedure . Have know allergy egg , chickens component vaccine ( include MF59 ) . Have immunosuppression include immunodeficiency disease . Have history GuillainBarre Syndrome . Have diagnosis thrombocytopenia . Have chronic disease investigator believe may interfere successful completion study . ( Excluding regulate hypertension ) Hemophilia Patients Are receive anticoagulating agent . Lowdose aspirin ( 100mg/day ) purpose prevention allow . Are receive antiviral agent . Have acute fever , temperature great 38℃ ( 100.4 degree Fahrenheit ) within 72 hour vaccination Have symptom acute febrile illness within 14 day prior vaccination study . Received agent expect receive agent within follow period . A . Have immunosuppression therapy , radiotherapy , use highdose glucocorticoid prednisolone ( ≥15mg/day ) within 6 month prior vaccination study.Inhaled , nasal topical steroid allow ) B . Have history receive immunoglobulin blood product within 3 month prior vaccination study . C. Received experimental agent within 1 month prior vaccination study . D. Received vaccine ( live license inactivated license ) within 1 month prior vaccination study . ( Excluding seasonal Influenza vaccine ) Those eligible receive vaccine injection arm deltoid muscle . Pregnant female , Nursing mom , Those woman chance become pregnant , take proper contraception . Not agree abstain drink follow 7 day vaccination . Have condition ( clinically regardful medical psychological condition ) would , opinion site investigator , render unable meet requirement protocol .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2010</verification_date>
</DOC>